Pharma giant Pfizer to raise some drug prices

November 17, 2018
Pfizer is ending a price freeze instituted following criticism from President Donald Trump, but 90 percent of its medicines will see no increase

Pfizer said Friday it would raise US prices on 41 drugs in January, reversing a price freeze implemented over the summer in the face of criticism by President Donald Trump.

The said the increases, which take effect January 15, apply to just 10 percent of its entire portfolio and would in many cases be offset by discounts to patients provided through and drug benefits, Pfizer said in a statement.

Trump attacked the company for raising in July, saying Pfizer "should be ashamed," which prompted a quick reversal, although a spokesperson at the time said the freeze would remain in place only until the end of the year.

As spokeswoman on Friday declined to specify which drugs would be subject to the five percent price hike, but The Wall Street Journal in July reported that they included a lung cancer treatment, blood pressure pills and popular pain medication Lyrica.

Three drugs will see prices rise just three percent, while one will jump nine percent "due to the completion of two extensive development programs that have led to the recent FDA approvals of two new medical uses that meet unmet patient needs."

"Given the higher rebates and discounts, we expect that the healthcare system will share those benefits with patients so they do not experience higher costs for their medicines," the company said.

The increases are not expected to affect revenue in 2019, Pfizer said, while prices subtracted one percent from revenue this year.

The company's share price closed the day with a gain of 0.7 percent.

Explore further: Drug prices going up despite Trump promise

Related Stories

Drug prices going up despite Trump promise

September 24, 2018
President Donald Trump made reducing drug prices a key promise during his election campaign, repeatedly accusing drugmakers of "getting away with murder." At the end of May, he promised that drug companies would be announcing ...

Novartis holds off on drug price hikes in US amid Trump pressure

July 18, 2018
Swiss pharmaceutical giant Novartis said Wednesday it would not hike drug prices in the United States this year, following a similar decision by rival Pfizer amid pressure from the White House.

Profit surges at Pfizer in 2Q on lower taxes, drug sales

July 31, 2018
Pfizer's second-quarter profit surged 26 percent, thanks to a 4 percent increase in medicine sales, higher income from partnerships and lower tax expenses.

Drugmakers to disclose prices for medicines advertised on TV

October 15, 2018
Drugmakers will start disclosing the prices for U.S. prescription drugs that are advertised on TV, but the Trump administration said the move announced Monday doesn't go far enough.

Pfizer reorganizes to handle aging consumers and patents

July 11, 2018
The drugmaker Pfizer, facing an aging population and shifting risks from the loss of patents, is reshaping its structure into three businesses.

Recommended for you

Early physical therapy can reduce risk, amount of long-term opioid use, study finds

December 14, 2018
Patients who underwent physical therapy soon after being diagnosed with pain in the shoulder, neck, low back or knee were approximately 7 to 16 percent less likely to use opioids in the subsequent months, according to a new ...

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Nov 18, 2018
USA is tired of paying ridiculous high prices for drugs so the rest of the world gets them for pennies

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.